Skip to content
Registered on Startup India District

COMPOSITE INTERCEPTIVE MED-SCIENCE LABORATORIES PRIVATE LIMITED

Sectors as filed: Health & Wellness

The website is as filed on the register. We have not checked that it resolves. Something wrong with this record?

Six things we look for on every record: DPIIT recognition, a CIN, a website, a description, a logo and a funding signal. Not held here: DPIIT recognised, Logo and Funding signal.

Where this is

District

Bengaluru

Karnataka

Startup India records the district. We do not have a street address for this company, and we will not invent one.

No point is drawn, because we do not have one.

Geocode confidence: medium

See all Bengaluru records on the map How we placed this record

What this record amounts to

COMPOSITE INTERCEPTIVE MED-SCIENCE LABORATORIES PRIVATE LIMITED is a Startup India record we can place no finer than Bengaluru district, which holds 34,244 records in this snapshot. 2,759 of those records are filed under Healthcare & Lifesciences, 8% of the district. It carries no funding signal of any class, which is true of 30,570 of the 34,244 records in Bengaluru.

Every figure above is counted from the 2026-08 snapshot and is the same number the page it links to prints.

In their own words

About CIMED : Composite Interceptive Med Science aims to create a novel genre of therapeutic solutions. It is based on creating composite pharmacology, capable of targeting interception of disease, along its continuum, even before the development of a diagnosable disease state or moving towards its final progression. The approach is not to replace current pharmaceutical standard of care, but to enable it scientifically and help its established approach, to optimise clinical outcomes. This is possible by a complex computational approach, combining genomic sequencing data from current medical research, related knowledge on pathophysiology of disease states, applying current rationale of pharmaceutical research and exploration of different systems of medicine. Conventional reductionist approach of drug discovery has restricted the landscape for innovative therapeutics. Highly focussed single target molecules are easily scalable and the synthetic processes being linked to quick clinical outcomes are easily regulated. . New research evidence shows, current form of targeted treatment as having multiple collateral effects, not easily justifiable with the cost of these treatments. CIMED offers a new Polymolecular approach to looking at medical therapeutics for the future. Here, diseases are modelled and a composite approach to management is created. CIMED is one of the first companies to work towards creating a composite pharmacology that can create Interceptive Medicine. It will be the first to put into practice, the knowledge of genetic predisposition to disease and help the individual to intercept or delay the onset or progression of diseases using CIMED drugs.

Written by the company on its public Startup India profile. Not verified by us.

What the record says

CIN
U73100KA2018PTC109264
Registered on Startup India
2019
Self-declared stage
Early traction
Healthcare & Lifesciences in Bengaluru
2,759 records
District
Bengaluru
State
Karnataka

The neighbourhood

This record carries no locality line, so the district is the finest ring we can place it in.

What we do not know

We have no liveness signal for any company on this site: no filings feed, no revenue, no check that the website still resolves. A record existing here means a record exists, not that a business is trading.

Is this your company?

Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, use the report link or write to trust@indianstartupmap.com.

How we built this record Where the data comes from How you may reuse it

Keep looking

One record is one row. Bengaluru has 34,244.

See Bengaluru